Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 70,678 shares at $26.52 ($1.9M) on 2023-03-30, disclosed to the SEC on 2023-04-03.
Scheduled sale ($1.9M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 35,339 | $937K | 50.0% |
| 2 | $26.52 | 35,339 | $937K | 50.0% |
| Total | $26.52 avg | 70,678 | $1.9M | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |